Get started
Author

Rolf Turk

Observed names: R Turk, R. R. Turk, R. Turk, Turk Rolf, Turk, Rolf
Observed institutions: University of Iowa, Centre National de la Recherche Scientifique, Howard Hughes Medical Institute, Leiden University Medical Center, Genethon (France), Integrated DNA Technologies (United States)
ORCID: 0000-0003-1283-9594
Observed ORCID: 0000-0003-1283-9594
OpenAlex ID: A5004412701
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
2018 · Christopher A. Vakulskas, Daniel P. Dever, et al. · Nature Medicine · 815
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
2020 · May Daher, Rafet Basar, et al. · Blood · 313
PDF
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
2021 · Liyang Zhang, John A. Zuris, et al. · Nature Communications · 166
PDF
Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain
2010 · Jakob S. Satz, Adam P. Ostendorf, et al. · Journal of Neuroscience · 155
PDF
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes
2017 · Ashley M. Jacobi, Garrett R. Rettig, et al. · Methods · 153
PDF
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair
2021 · Mollie S. Schubert, Bernice Thommandru, et al. · Scientific Reports · 131
PDF
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling
2005 · R Turk, E Sterrenburg, et al. · BMC Genomics · 109
PDF
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells
2022 · Jonas Kath, Weijie Du, et al. · Molecular Therapy — Methods & Clinical Development · 100
PDF
Generation and Characterization of Transgenic Mice with the Full-length Human DMD Gene
2007 · Peter A.C. 't Hoen, Emile J. de Meijer, et al. · Journal of Biological Chemistry · 95
Common pathological mechanisms in mouse models for muscular dystrophies
2005 · R. Turk, E. Sterrenburg, et al. · The FASEB Journal · 79
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
2020 · Jenny Shapiro, Ortal Iancu, et al. · Molecular Therapy — Methods & Clinical Development · 72
PDF
Visual Impairment in the Absence of Dystroglycan
2009 · Jakob S. Satz, Alisdair R. Philp, et al. · Journal of Neuroscience · 69
PDF
Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle
2016 · Erik P. Rader, Rolf Turk, et al. · Proceedings of the National Academy of Sciences · 50
Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development
2017 · Reena Clements, Rolf Turk, et al. · Journal of Neuroscience · 45
PDF
An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies
2023 · Jingyu Xiang, Jessica M. Devenport, et al. · Leukemia · 44
PDF
Large-scale gene expression analysis of human skeletal myoblast differentiation
2004 · Ellen Sterrenburg, Rolf Turk, et al. · Neuromuscular Disorders · 40
Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan
2012 · Marie-Laurence Moraz, Christelle Pythoud, et al. · Cellular Microbiology · 35
PDF
Gene expression variation between mouse inbred strains
2004 · Rolf Turk, Peter AC 't Hoen, et al. · BMC Genomics · 34
PDF
CRISPAltRations: A validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing
2021 · Gavin Kurgan, Rolf Turk, et al. · Molecular Therapy — Methods & Clinical Development · 31
Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
2020 · Rafet Basar, May Daher, et al. · Blood Advances · 31
Gene expression profiling highlights defective myogenesis in DMD patients and a possible role for bone morphogenetic protein 4
2006 · Ellen Sterrenburg, Caroline G.C. van der Wees, et al. · Neurobiology of Disease · 25
Molecular Signatures of Membrane Protein Complexes Underlying Muscular Dystrophy
2016 · Rolf Turk, Jordy J. Hsiao, et al. · Molecular & Cellular Proteomics · 24
Gene Expression Profiling to Monitor Therapeutic and Adverse Effects of Antisense Therapies for Duchenne Muscular Dystrophy
2006 · Peter AC ’t Hoen, Caroline GC van der Wees, et al. · Pharmacogenomics · 24
Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency
2021 · Sara Fañanas-Baquero, Oscar Quintana-Bustamante, et al. · Molecular Therapy — Methods & Clinical Development · 22
PDF
Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12a
2020 · Wenqing Li, Chun Chan, et al. · Bioconjugate Chemistry · 11
Works count: 50
Citation count: 2,717
H-index: 23
I10-index: 26
Year
Topic
Type